\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ entered\ \(0\)\
\-\ she\\ was\\ referred\\ to\\ radiology\\ for\\ followup\\ evaluation\\ and\\ subsequent\\ ct\\-guided\\ biopsy\\ of\\ the\\ liver\\ lesion\\.\ \(0\)\
\-\ suspicious\\ metastases\\ in\\ the\\ liver\\,\\ lungs\\,\\ and\\ bone\\.\\ biopsy\\ from\\ liver\\.\ \(0\)\
\-\ \\(\\#56\\)\\ 3\\.3\\ x\\ 3\\.2\\ cm\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\.\\ \ \(1\)\
\-\ \\(\\#59\\)\\ additional\\ 3\\.3\\ x\\ 2\\.7\\ cm\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\.\ \(0\)\
\-\ \\(\\#66\\)\\ additional\\ 1\\.6\\ cm\\ diameter\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\ close\\ to\\ parenchymal\\ edge\\.\ \(0\)\
\-\ \\(\\#23\\,\\ \\#28\\,\\ \\#35\\)\\ numerous\\ lung\\ nodules\\ on\\ bilateral\\ lung\\ fields\\.\ \(0\)\
\-\ \\(\\#98\\)\\ well\\ defined\\ lucencies\\ noted\\ within\\ right\\ iliac\\ in\\ proximity\\ to\\ sacroiliac\\ joint\\.\ \(1\)\
\-\ liver\\ metastases\\ from\\ breast\\ cancer\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ primary\\ neoplasm\ \(4\)\
\-\ cystic\\ mass\ \(109\)\
\-\ 46\\ yo\\ woman\\ with\\ a\\ 15\\ year\\ history\\ of\\ breast\\ cancer\\ referred\\ to\\ radiology\\ for\\ followup\\ evaluation\\.\ \(1\)\
\-\ liver\\ metastases\\ from\\ breast\\ cancer\\ is\\ usually\\ a\\ late\\ finding\\ and\\ as\\ this\\ case\\ indicates\\,\\ possible\\ other\\ metastases\\ have\\ already\\ occurred\\ to\\ other\\ organ\\ systems1\\,2\\.\\ \\ it\\ is\\ therefore\\ essential\\ to\\ have\\ diligent\\ follow\\ up\\ of\\ treated\\ primary\\ breast\\ cancer\\ patients\\.\\ \\ \\ thorough\\ history\\ and\\ physical\\ \\(review\\ of\\ system\\ for\\ systemic\\ recurrence\\,\\ and\\ complete\\ physical\\ looking\\ for\\ locoregional\\ recurrence\\)\\ is\\ recommended\\ every\\ 3\\-6\\ months\\ for\\ the\\ first\\ 3\\ years\\ post\\ primary\\ therapy\\ and\\ then\\ every\\ 6\\-12\\ months\\ for\\ 2\\ years\\ and\\ then\\ annually3\\.\\ \\ mammography\\ should\\ be\\ taken\\ every\\ 6\\ months\\ after\\ radiation\\ treatment\\ if\\ the\\ patient\\ had\\ breast\\ conserving\\ surgical\\ treatment\\.\\ \\ yearly\\ mammography\\ should\\ be\\ taken\\ for\\ those\\ that\\ did\\ not\\ have\\ breast\\ conserving\\ surgery3\\.\\ \\ patients\\ should\\ also\\ conduct\\ monthly\\ breast\\ examinations3\\.\\ \\ pelvic\\ examination\\ should\\ be\\ conducted\\ regularly\\,\\ but\\ could\\ be\\ extended\\ if\\ patient\\ has\\ had\\ total\\ hysterectomy\\ and\\ oophorectomy3\\.\\ \\ if\\ the\\ patient\\ had\\ isolated\\ and\\ single\\ liver\\ metastases\\ then\\ the\\ patient\\ may\\ be\\ a\\ good\\ candidate\\ for\\ surgical\\ resection\\.\\ \\ however\\,\\ due\\ to\\ possibility\\ of\\ extrahepatic\\ lesions\\ and\\ numerous\\ liver\\ metastases\\,\\ the\\ patient\\ in\\ the\\ case\\ is\\ not\\ a\\ good\\ surgical\\ candidate1\\,2\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ liver\\:\\ 0\\.0834623657459695\ \(0\)\
\-\ \\#\\:\\ 0\\.06646404060222724\ \(0\)\
\-\ breast\\:\\ 0\\.06251531333375032\ \(0\)\
\-\ metastases\\:\\ 0\\.06205210963245866\ \(0\)\
\-\ conserving\\:\\ 0\\.04372184779205886\ \(0\)\
\-\ every\\:\\ 0\\.0385738156228083\ \(0\)\
\-\ 3\\.3\\:\\ 0\\.03389407977286279\ \(0\)\
\-\ cancer\\:\\ 0\\.031831901012631905\ \(0\)\
\-\ should\\:\\ 0\\.03086921860497224\ \(0\)\
\-\ mammography\\:\\ 0\\.028132412590688046\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.026704208131402316\ \(0\)\
\-\ then\\:\\ 0\\.02584391114806309\ \(0\)\
\-\ systems1\\,2\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ annually3\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ surgery3\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ examinations3\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ oophorectomy3\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ candidate1\\,2\\:\\ 0\\.02497314001123654\ \(0\)\
\-\ followup\\:\\ 0\\.02311229447916149\ \(0\)\
\-\ locoregional\\:\\ 0\\.0230095502646078\ \(0\)\
\-\ conduct\\:\\ 0\\.0230095502646078\ \(0\)\
\-\ diligent\\:\\ 0\\.02186092389602943\ \(0\)\
\-\ numerous\\:\\ 0\\.021710548454720466\ \(0\)\
\-\ primary\\:\\ 0\\.021513180704496006\ \(0\)\
\-\ recurrence\\:\\ 0\\.021121371607558722\ \(0\)\
\-\ good\\:\\ 0\\.02071650495610181\ \(0\)\
\-\ radiology\\:\\ 0\\.020461822871896334\ \(0\)\
\-\ taken\\:\\ 0\\.020188356917393024\ \(0\)\
\-\ months\\:\\ 0\\.01983519513900907\ \(0\)\
\-\ if\\:\\ 0\\.01970603484799407\ \(0\)\
\-\ lobe\\:\\ 0\\.01954100862257961\ \(0\)\
\-\ cm\\:\\ 0\\.019478380604676937\ \(0\)\
\-\ 6\\-12\\:\\ 0\\.019460646671136502\ \(0\)\
\-\ additional\\:\\ 0\\.019413295717563724\ \(0\)\
\-\ entered\\:\\ 0\\.019082370771350318\ \(0\)\
\-\ be\\:\\ 0\\.018665109395806363\ \(0\)\
\-\ ct\\-guided\\:\\ 0\\.01845023606507777\ \(0\)\
\-\ referred\\:\\ 0\\.01826929996292148\ \(0\)\
\-\ monthly\\:\\ 0\\.018180235555717076\ \(0\)\
\-\ regularly\\:\\ 0\\.01793374440277195\ \(0\)\
\-\ thorough\\:\\ 0\\.017497056924507762\ \(0\)\
\-\ biopsy\\:\\ 0\\.017176732247233772\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.01678511803419358\ \(0\)\
\-\ 3\\-6\\:\\ 0\\.01678511803419358\ \(0\)\
\-\ posterior\\:\\ 0\\.016739137807669537\ \(0\)\
\-\ for\\:\\ 0\\.01652369741966493\ \(0\)\
\-\ proximity\\:\\ 0\\.016486646318449028\ \(0\)\
\-\ yearly\\:\\ 0\\.01634843055592939\ \(0\)\
\-\ sacroiliac\\:\\ 0\\.016216645809088336\ \(0\)\
\-\ 2\\.7\\:\\ 0\\.01609072013608314\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.01609072013608314\ \(0\)\
\-\ x\\:\\ 0\\.015972047225764743\ \(0\)\
\-\ conducted\\:\\ 0\\.01597015465614321\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.01597015465614321\ \(0\)\
\-\ have\\:\\ 0\\.015726102648995117\ \(0\)\
\-\ had\\:\\ 0\\.015670111778249646\ \(0\)\
\-\ essential\\:\\ 0\\.01533801994987066\ \(0\)\
\-\ looking\\:\\ 0\\.01533801994987066\ \(0\)\
\-\ surgical\\:\\ 0\\.015265340823666746\ \(0\)\
\-\ 1\\.6\\:\\ 0\\.015155191278092837\ \(0\)\
\-\ 98\\:\\ 0\\.014983450139802654\ \(0\)\
\-\ candidate\\:\\ 0\\.014901332471606472\ \(0\)\
\-\ lucencies\\:\\ 0\\.014523056571820289\ \(0\)\
\-\ already\\:\\ 0\\.01438484080930065\ \(0\)\
\-\ seen\\:\\ 0\\.014350942904257992\ \(0\)\
\-\ indicates\\:\\ 0\\.014253056062459595\ \(0\)\
\-\ years\\:\\ 0\\.014216674997271856\ \(0\)\
\-\ organ\\:\\ 0\\.014189393581292292\ \(0\)\
\-\ evaluation\\:\\ 0\\.014063675897035739\ \(0\)\
\-\ lung\\:\\ 0\\.014023564420616126\ \(0\)\
\-\ extended\\:\\ 0\\.01400656490951447\ \(0\)\
\-\ edge\\:\\ 0\\.01356987743125028\ \(0\)\
\-\ mass\\:\\ 0\\.013466980248697616\ \(0\)\
\-\ fields\\:\\ 0\\.013191601531464097\ \(0\)\
\-\ 59\\:\\ 0\\.013019860393173913\ \(0\)\
\-\ 66\\:\\ 0\\.013019860393173913\ \(0\)\
\-\ 46\\:\\ 0\\.012818863973988973\ \(0\)\
\-\ occurred\\:\\ 0\\.012818863973988973\ \(0\)\
\-\ 56\\:\\ 0\\.012742295496969373\ \(0\)\
\-\ late\\:\\ 0\\.012595100769120331\ \(0\)\
\-\ isolated\\:\\ 0\\.012595100769120331\ \(0\)\
\-\ patients\\:\\ 0\\.012530167701790515\ \(0\)\
\-\ \\(\\:\\ 0\\.012278102995646356\ \(0\)\
\-\ possibility\\:\\ 0\\.01222580383466355\ \(0\)\
\-\ patient\\:\\ 0\\.01213303018295167\ \(0\)\
\-\ \\)\\:\\ 0\\.012128119412690739\ \(0\)\
\-\ iliac\\:\\ 0\\.012072638901886566\ \(0\)\
\-\ parenchymal\\:\\ 0\\.011899144212819374\ \(0\)\
\-\ physical\\:\\ 0\\.01187821682482288\ \(0\)\
\-\ close\\:\\ 0\\.011816225282790725\ \(0\)\
\-\ suspicious\\:\\ 0\\.011657331609558307\ \(0\)\
\-\ systemic\\:\\ 0\\.011581106530465035\ \(0\)\
\-\ 23\\:\\ 0\\.011506878846629275\ \(0\)\
\-\ therefore\\:\\ 0\\.011434546546331357\ \(0\)\
\-\ 28\\:\\ 0\\.01141084045661318\ \(0\)\
\-\ other\\:\\ 0\\.011159425205113024\ \(0\)\
\-\ 35\\:\\ 0\\.011140839947252486\ \(0\)\
\-\ those\\:\\ 0\\.011014914274247292\ \(0\)\
\-\ from\\:\\ 0\\.010762909743520219\ \(0\)\
\-\ case\\:\\ 0\\.010592093104063857\ \(0\)\
\-\ not\\:\\ 0\\.010494209674860642\ \(0\)\
\-\ review\\:\\ 0\\.010491588202861063\ \(0\)\
\-\ total\\:\\ 0\\.010424135940272625\ \(0\)\
\-\ right\\:\\ 0\\.0102167899049339\ \(0\)\
\-\ defined\\:\\ 0\\.01019995089619692\ \(0\)\
\-\ diameter\\:\\ 0\\.010184596597416922\ \(0\)\
\-\ nodules\\:\\ 0\\.010035464207939807\ \(0\)\
\-\ recommended\\:\\ 0\\.010035464207939807\ \(0\)\
\-\ pelvic\\:\\ 0\\.009935554466190632\ \(0\)\
\-\ single\\:\\ 0\\.009812068811587625\ \(0\)\
\-\ treatment\\:\\ 0\\.009799529516152336\ \(0\)\
\-\ 15\\:\\ 0\\.009655372953275863\ \(0\)\
\-\ system\\:\\ 0\\.009531104732013592\ \(0\)\
\-\ subsequent\\:\\ 0\\.009423741353568871\ \(0\)\
\-\ lungs\\:\\ 0\\.009166539937621178\ \(0\)\
\-\ could\\:\\ 0\\.008930759047678618\ \(0\)\
\-\ did\\:\\ 0\\.008740562722359558\ \(0\)\
\-\ complete\\:\\ 0\\.008519478566532733\ \(0\)\
\-\ to\\:\\ 0\\.008468772688671116\ \(0\)\
\-\ neoplasm\\:\\ 0\\.008244069620147105\ \(0\)\
\-\ possible\\:\\ 0\\.008152924132816068\ \(0\)\
\-\ first\\:\\ 0\\.008123182534804114\ \(0\)\
\-\ radiation\\:\\ 0\\.007944054531338065\ \(0\)\
\-\ joint\\:\\ 0\\.007828411487371335\ \(0\)\
\-\ finding\\:\\ 0\\.007801873951950373\ \(0\)\
\-\ follow\\:\\ 0\\.007691783206647123\ \(0\)\
\-\ post\\:\\ 0\\.007622762133349274\ \(0\)\
\-\ resection\\:\\ 0\\.007549336134618184\ \(0\)\
\-\ examination\\:\\ 0\\.00752527772089112\ \(0\)\
\-\ usually\\:\\ 0\\.007351071540699035\ \(0\)\
\-\ yo\\:\\ 0\\.0072842819357018754\ \(0\)\
\-\ treated\\:\\ 0\\.007246036362843794\ \(0\)\
\-\ 6\\:\\ 0\\.007229802156869332\ \(0\)\
\-\ in\\:\\ 0\\.0071625591525255805\ \(0\)\
\-\ cystic\\:\\ 0\\.006981962343489401\ \(0\)\
\-\ \\,\\:\\ 0\\.006901956344633389\ \(0\)\
\-\ she\\:\\ 0\\.006795428162759695\ \(0\)\
\-\ however\\:\\ 0\\.006740419420954874\ \(0\)\
\-\ history\\:\\ 0\\.006686767919020303\ \(0\)\
\-\ up\\:\\ 0\\.006509482014317914\ \(0\)\
\-\ lesions\\:\\ 0\\.006480341377744895\ \(0\)\
\-\ therapy\\:\\ 0\\.006472070244307686\ \(0\)\
\-\ due\\:\\ 0\\.006459708648591614\ \(0\)\
\-\ is\\:\\ 0\\.006371566893877911\ \(0\)\
\-\ metastatic\\:\\ 0\\.006093794344521502\ \(0\)\
\-\ bone\\:\\ 0\\.0060153956981866\ \(0\)\
\-\ bilateral\\:\\ 0\\.005874837760097575\ \(0\)\
\-\ noted\\:\\ 0\\.005737737077769388\ \(0\)\
\-\ 3\\:\\ 0\\.005668485911349971\ \(0\)\
\-\ woman\\:\\ 0\\.005591793052376505\ \(0\)\
\-\ well\\:\\ 0\\.005476150008409776\ \(0\)\
\-\ it\\:\\ 0\\.005441496840036875\ \(0\)\
\-\ may\\:\\ 0\\.0053097120931958185\ \(0\)\
\-\ 2\\:\\ 0\\.0052127606133443236\ \(0\)\
\-\ but\\:\\ 0\\.005162898869783393\ \(0\)\
\-\ and\\:\\ 0\\.005099405261535934\ \(0\)\
\-\ after\\:\\ 0\\.0050085019903943415\ \(0\)\
\-\ lesion\\:\\ 0\\.004930751348443215\ \(0\)\
\-\ also\\:\\ 0\\.004772293466487681\ \(0\)\
\-\ within\\:\\ 0\\.004617936001093716\ \(0\)\
\-\ has\\:\\ 0\\.004545892267689173\ \(0\)\
\-\ a\\:\\ 0\\.004494048745819845\ \(0\)\
\-\ that\\:\\ 0\\.004181248522829528\ \(0\)\
\-\ disease\\:\\ 0\\.00395676357284902\ \(0\)\
\-\ as\\:\\ 0\\.0036616926512581527\ \(0\)\
\-\ the\\:\\ 0\\.0031331282652379785\ \(0\)\
\-\ was\\:\\ 0\\.0027996530374325406\ \(0\)\
\-\ this\\:\\ 0\\.002722768309671765\ \(0\)\
\-\ year\\:\\ 0\\.0027085135106881437\ \(0\)\
\-\ of\\:\\ 0\\.002640312765960078\ \(0\)\
\-\ on\\:\\ 0\\.0020506827545762837\ \(0\)\
\-\ \\.\\:\\ 0\\.0018101746451904615\ \(0\)\
\-\ with\\:\\ 0\\.00033145658948977263\ \(0\)\
